DRAP has issued a directive integrating the eAPP system (licensing and product registration) with the national Drug Track and Trace System.
What changes
The Track and Trace System will now fetch manufacturing licence and product registration details directly from eAPP. These are the exact data points required to generate 2D barcodes and serial numbers. Manual entry of product or licensing data inside the Track and Trace System will no longer be permitted.
What industry has to do
Verify and validate all licensing and product data on the eAPP portal on or before 25 August 2026. The portal locks after that date, and no requests for validation, correction, or modification will be entertained afterwards.
Why this matters
Master data is where most serialization programmes quietly fail. If the product registration record is wrong, the barcode is wrong, and every event downstream inherits the error. By making eAPP the single source of truth and closing the manual entry door, DRAP is removing an entire category of data quality problems before the system scales.
This follows the June 2026 memorandum on 2D barcode and serialization requirements under the Drugs (Labelling and Packing) Rules 1986, notified through S.R.O. 963(I)/2026 dated 09.06.2026, and the DRAP serialization guidelines that took effect on 28 July 2026.
Pakistan is taking this seriously. The sequence has been consistent and deliberate: rules first, then guidelines, now system integration with a hard deadline attached.
Manufacturers and importers with products registered in Pakistan should treat 25 August as a firm date, not an aspirational one.
#TrackAndTrace #Serialization #DRAP #Pakistan #PharmaSupplyChain #TraceHub